In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Two drugs, two different destinies. Does their story prove that business practice makes the difference?

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

Five quotes to end the year in style – and thoughtfulness.

Sitting Down With… Tunde Bello, Vice President of Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, New Jersey, USA.

Oxford University spinout OxSonics has developed a unique use for ultrasound technology to make anticancer treatment more effective

Pharma depends on academia, but that relationship can become better… and more fluid

Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.